| 000 | 01442 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516105053.0 | ||
| 264 | 0 | _c20120910 | |
| 008 | 201209s 0 0 rus d | ||
| 022 | _a0507-3758 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPetrunin, D D | |
| 245 | 0 | 0 |
_a[Aproaches to immunotherapy in different immunophenotypes of cutaneous basal cell carcinoma]. _h[electronic resource] |
| 260 |
_bVoprosy onkologii _c2012 |
||
| 300 |
_a406-12, 415 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcridines _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCarcinoma, Basal Cell _ximmunology |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin A _xblood |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 |
_aImmunoglobulin M _xblood |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 | _aInjections |
| 650 | 0 | 4 |
_aInterferon Inducers _xadministration & dosage |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSkin Neoplasms _ximmunology |
| 650 | 0 | 4 | _aSuppositories |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aOkovityĭ, S V | |
| 700 | 1 | _aKostalevskaia, A V | |
| 700 | 1 | _aSuchkov, S V | |
| 773 | 0 |
_tVoprosy onkologii _gvol. 58 _gno. 3 _gp. 406-12, 415 |
|
| 999 |
_c22020884 _d22020884 |
||